Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Disc Medicine's LP, Insider told the SEC about a plan to sell $1.1M of Disc Medicine shares around Oct 21, 2026. The shares were not acquired as compensation. That is a tiny part of all Disc Medicine shares.
Disc Medicine's LP, Insider told the SEC about a plan to sell $912K of Disc Medicine shares around Oct 21, 2026. The shares were not acquired as compensation. That is a tiny part of all Disc Medicine shares.
Disc Medicine's LP, Insider told the SEC about a plan to sell $21K of Disc Medicine shares around Oct 21, 2026. The shares were not acquired as compensation.
Disc Medicine's LP, Insider told the SEC about a plan to sell $226K of Disc Medicine shares around Oct 20, 2026. The shares were not acquired as compensation.
Disc Medicine's LP, Insider told the SEC about a plan to sell $188K of Disc Medicine shares around Oct 20, 2026. The shares were not acquired as compensation.
Disc Medicine's LP, Insider told the SEC about a plan to sell $4.3K of Disc Medicine shares around Oct 20, 2026. The shares were not acquired as compensation.
Disc Medicine's LP, Insider told the SEC about a plan to sell $819K of Disc Medicine shares around Oct 19, 2026. The shares were not acquired as compensation. That is a tiny part of all Disc Medicine shares.
Disc Medicine's LP, Insider told the SEC about a plan to sell $337K of Disc Medicine shares around Oct 19, 2026. The shares were not acquired as compensation. That is a tiny part of all Disc Medicine shares.
Disc Medicine's LP, Insider told the SEC about a plan to sell $281K of Disc Medicine shares around Oct 19, 2026. The shares were not acquired as compensation. That is a tiny part of all Disc Medicine shares.
Disc Medicine's LP, Insider told the SEC about a plan to sell $6.5K of Disc Medicine shares around Oct 19, 2026. The shares were not acquired as compensation.
0 open-market purchases and 10 open-market sales by insiders of IRON between Apr 5, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Nov 5, 2026. The data provider lists the next release for Feb 24, 2027; that date may change.
PurchaseSale30 days before a release30 days after
Trades in the 30 days around each of the last earnings releases
William Jacob Savage, Chief Medical Officer, Nov 10, 2026, about $1.36M. Sold 5 days after the company's previous earnings release on 2026-11-05Form 4
Kevin Bitterman, Director, Oct 21, 2026, about $21K. Sold 1 day before the company's next earnings release on 2026-10-22Form 4
Kevin Bitterman, Director, Oct 21, 2026, about $920K. Sold 1 day before the company's next earnings release on 2026-10-22Form 4
Kevin Bitterman, Director, Oct 21, 2026, about $1.11M. Sold 1 day before the company's next earnings release on 2026-10-22Form 4
, Director, Oct 20, 2026, about $4.4K. Sold 2 days before the company's next earnings release on 2026-10-22
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies